Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The licensed technology combines Alterity’s PBT2 and other zinc ionophores with commonly used antibiotics to treat infections caused by multidrug resistant bacteria. This is an opportunity for Alterity to further leverage its investment in PBT2.
Lead Product(s): PBT2
Therapeutic Area: Infections and Infectious Diseases Product Name: PBT2
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Alterity Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership December 21, 2020